Simplex Trading
XERS icon

Simplex Trading’s Xeris Biopharma Holdings XERS Stock Holding History

Simplex Trading’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36K Buy
+6,200
New +$41.1K ﹤0.01% 6202
2025
Q4 		– Sell
-19,300
Closed -$157K – 10293
2025
Q3 		$157K Buy
19,300
+5,100
+36% +$33.9K ﹤0.01% 5222
2025
Q2 		$66K Buy
14,200
+7,600
+115% +$34.8K ﹤0.01% 5652
2025
Q1 		$36K Buy
6,600
+5,800
+725% +$23.4K ﹤0.01% 6102
2024
Q4 		$2K Sell
800
-10,000
-93% -$32.2K ﹤0.01% 8105
2024
Q3 		$30K Sell
10,800
-12,000
-53% -$30.8K ﹤0.01% 6363
2024
Q2 		$51K Buy
22,800
+300
+1% +$605 ﹤0.01% 6076
2024
Q1 		$49K Buy
22,500
+10,500
+88% +$27.2K ﹤0.01% 6288
2023
Q4 		$28K Hold
12,000
– – ﹤0.01% 6639
2023
Q3 		$22K Sell
12,000
-100
-0.8% -$229 ﹤0.01% 6557
2023
Q2 		$31K Buy
12,100
+10,300
+572% +$26.2K ﹤0.01% 6333
2023
Q1 		$2K Sell
1,800
-100
-5% -$125 ﹤0.01% 8556
2022
Q4 		$2K Buy
1,900
+700
+58% +$988 ﹤0.01% 8674
2022
Q3 		$1K Sell
1,200
-22,000
-95% -$36.4K ﹤0.01% 9678
2022
Q2 		$35K Buy
23,200
+20,900
+909% +$44.1K ﹤0.01% 6958
2022
Q1 		$5K Sell
2,300
-125,600
-98% -$307K ﹤0.01% 9465
2021
Q4 		$374K Buy
127,900
+19,400
+18% +$41.9K ﹤0.01% 4231
2021
Q3 		$452K Sell
108,500
-300
-0.3% -$871 ﹤0.01% 4246
2021
Q2 		$442K Buy
108,800
+108,775
+435,100% +$415K ﹤0.01% 4358
2021
Q1 		$11K Sell
25
-111
-82% -$599 ﹤0.01% 7855
2020
Q4 		$66K Buy
136
+64
+89% +$320 ﹤0.01% 5879
2020
Q3 		$42K Buy
+72
New +$288 ﹤0.01% 5783

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's XERS Position: Q4 2025 in Review

Simplex Trading sold out of Xeris Biopharma Holdings (XERS) in Q4 2025, closing a stake of 45,931 shares — an estimated $373K sold.

Simplex Trading first reported a position in XERS in Q2 2020 and held it in 9 quarters. The position peaked at $941K in Q4 2021. 225 funds tracked by Wall St. Rank hold XERS as of Q4 2025.

  • Simplex Trading reported no remaining Xeris Biopharma Holdings position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 45,931 Xeris Biopharma Holdings shares in Q4 2025, an estimated $373K.
  • Simplex Trading first reported a position in Xeris Biopharma Holdings in Q2 2020 and held it in 9 quarters.
  • Simplex Trading's Xeris Biopharma Holdings position peaked at $941K in Q4 2021.
  • 225 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.